Cost–benefit analysis of universal screening for HCV infection in China: a Markov modelling study
文献类型：期刊论文
| 作者 | Dachuang Zhou6; Liangxiu Xu6; Yimei Zhong6; Zhehong Xu5; Jun Wang4; Yuntian Wang3; Yiyang Gao6; Jing Xie1; Yuting Xia6; Wenxi Tang6 |
| 刊名 | BMC HEALTH SERVICES RESEARCH
 |
| 出版日期 | 2025 |
| 卷号 | 25期号:1页码:1 |
| ISSN号 | 1472-6963 |
| 英文摘要 | Hepatitis C virus (HCV) infection remains a major public health concern in China, contributing substantially to global HCV-related morbidity and mortality. In line with the World Health Organization (WHO) targets for HCV elimination by 2030, this study aimed to evaluate the long-term health and economic outcomes of universal HCV screening strategies in China. |
| 语种 | 英语 |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/319268]  |
| 专题 | 中国科学院上海药物研究所 |
| 作者单位 | 1.东南大学 2.海南大学 3.中国科学院 4.中国科学院上海药物研究所 5.厦门大学 6.中国药科大学 |
| 推荐引用方式 GB/T 7714 | Dachuang Zhou,Liangxiu Xu,Yimei Zhong,et al. Cost–benefit analysis of universal screening for HCV infection in China: a Markov modelling study[J]. BMC HEALTH SERVICES RESEARCH,2025,25(1):1. |
| APA | Dachuang Zhou.,Liangxiu Xu.,Yimei Zhong.,Zhehong Xu.,Jun Wang.,...&Wenxi Tang.(2025).Cost–benefit analysis of universal screening for HCV infection in China: a Markov modelling study.BMC HEALTH SERVICES RESEARCH,25(1),1. |
| MLA | Dachuang Zhou,et al."Cost–benefit analysis of universal screening for HCV infection in China: a Markov modelling study".BMC HEALTH SERVICES RESEARCH 25.1(2025):1. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。